53. Dai W (2004) Degradation of a non-cycling mammalian polo-like kinase. Cell Cycle 3: 625–626. 54. Xie S, Wu H, Wang Q, Kunicki J, Thomas RO, et al. (2002) Genotoxic stress- induced activation of Plk3 is partly mediated by Chk2. Cell Cycle 1: 424–429. 55. Lowery DM, Lim D, Yaffe MB (2005) Structure and function of Polo-like kinases. Oncogene 24: 248–259. 56. Ko MA, Rosario CO, Hudson JW, Kulkarni S, Pollett A, et al. (2005) Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nat Genet 37: 883–888. 57. Bettencourt-Dias M, Rodrigues-Martins A, Carpenter L, Riparbelli M, Lehmann L, et al. (2005) SAK/PLK4 is required for centriole duplication and flagella development. Curr Biol 15: 2199–2207. 58. Kleylein-Sohn J, Westendorf J, Le Clech M, Habedanck R, Stierhof YD, et al. (2007) Plk4-induced centriole biogenesis in human cells. Dev Cell 13: 190–202. 59. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA (2005) The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 7: 1140–1146. 60. Georgescu SP, Komuro I, Hiroi Y, Mizuno T, Kudoh S, et al. (1997) Downregulation of polo-like kinase correlates with loss of proliferative ability of cardiac myocytes. J Mol Cell Cardiol 29: 929–937. 61. Chow JP, Siu WY, Ho HT, Ma KH, Ho CC, et al. (2003) Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints. J Biol Chem 278: 40815–40828. 62. Li JM, Brooks G (1997) Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy. Am J Physiol 273: H1358–1367. 63. Poolman RA, Gilchrist R, Brooks G (1998) Cell cycle profiles and expressions of p21CIP1 AND P27KIP1 during myocyte development. Int J Cardiol 67: 133–142. 64. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311–322. 65. Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, et al. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106: 348–360. 66. Van Hooser A, Goodrich DW, Allis CD, Brinkley BR, Mancini MA (1998) Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation. J Cell Sci 111 (Pt 23): 3497–3506. 67. Allison SJ, Milner J (2003) Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. Cancer Res 63: 6674–6679. Plk1 & Myocardial Regeneration 68. Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, et al. (1999) Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem 274: 25543–25549. 69. Winkles JA, Alberts GF (2005) Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues. Oncogene 24: 260–266. 70. Li F, Wang X, Gerdes AM (1997) Formation of binucleated cardiac myocytes in rat heart: II. Cytoskeletal organisation. J Mol Cell Cardiol 29: 1553–1565. 71. Clubb FJ Jr, Bishop SP (1984) Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. Lab Invest 50: 571–577. 72. Li F, Wang X, Bunger PC, Gerdes AM (1997) Formation of binucleated cardiac myocytes in rat heart: I. Role of actin-myosin contractile ring. J Mol Cell Cardiol 29: 1541–1551. 73. Li F, Wang X, Capasso JM, Gerdes AM (1996) Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737–1746. 74. Li JM, Brooks G (1999) Cell cycle regulatory molecules (cyclins, cyclin- dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovas- cular system; potential targets for therapy? Eur Heart J 20: 406–420. 75. Donohue PJ, Alberts GF, Guo Y, Winkles JA (1995) Identification by targeted differential display of an immediate early gene encoding a putative serine/ threonine kinase. J Biol Chem 270: 10351–10357. 76. Bahassi el M, Conn CW, Myer DL, Hennigan RF, McGowan CH, et al. (2002) Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene 21: 6633–6640. 77. Bahassi el M, Myer DL, McKenney RJ, Hennigan RF, Stambrook PJ (2006) Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage. Mutat Res 596: 166–176. 78. Xie S, Wu H, Wang Q, Cogswell JP, Husain I, et al. (2001) Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem 276: 43305–43312. 79. Kaldis P, Solomon MJ (2000) Analysis of CAK activities from human cells. Eur J Biochem 267: 4213–4221. 80. Desai D, Wessling HC, Fisher RP, Morgan DO (1995) Effects of phosphory- lation by CAK on cyclin binding by CDC2 and CDK2. Mol Cell Biol 15: 345–350. 81. Ferrari S (2006) Protein kinases controlling the onset of mitosis. Cell Mol Life Sci 63: 781–795. 82. Meckert PC, Rivello HG, Vigliano C, Gonzalez P, Favaloro R, et al. (2005) Endomitosis and polyploidization of myocardial cells in the periphery of human acute myocardial infarction. Cardiovasc Res 67: 116–123. PLoS ONE | www.plosone.org 12 August 2009 | Volume 4 | Issue 8 | e6752